Matthew Paul Del Giudice - Mar 25, 2024 Form 4 Insider Report for MIRA PHARMACEUTICALS, INC. (MIRA)

Role
Director
Signature
/s/ Matthew Del Giudice
Stock symbol
MIRA
Transactions as of
Mar 25, 2024
Transactions value $
$0
Form type
4
Date filed
3/27/2024, 05:53 PM
Previous filing
Mar 22, 2024
Next filing
Aug 15, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MIRA Nonqualified Stock Option (right to buy) Award $0 +50K $0.00 25K Mar 25, 2024 Common Stock 50K $1.16 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options were granted under the Issuer's 2022 Omnibus Incentive Plan whereby 50% of such options, or 25,000 options, vested immediately on the grant date of March 25, 2024, and the remaining 50% vest on the first anniversary of the grant date, March 25, 2025.